The serotonin transporter gene (SLC6A4) is a candidate gene for schizophrenia based on serotonin transporter's crucial role in serotonergic neurotransmission. However, association studies have produced conflicting results regarding the association between two common SLC6A4 gene polymorphisms, the promoter insertion/deletion (5-HTTLPR) and the intron 2 VNTR (STin2 VNTR) polymorphisms, and schizophrenia susceptibility. To further elucidate the putative association between the two SLC6A4 gene polymorphisms and schizophrenia susceptibility, we performed a meta-analysis based on all original published association studies between schizophrenia and the 5-HTTLPR and STin2 VNTR polymorphisms published before April 2004. Our analyses showed no statistically significant evidence for the association between the Short allele of the 5-HTTLPR polymorphism and schizophrenia (random-effects pooled odds ratio (OR) ¼ 0.99, 95% Confidence Interval (CI) ¼ 0.92-1.07, Z ¼ À0.23, P ¼ 0.82) from 19 population-based association studies consisting of 2990 case and 3875 control subjects. However, highly significant evidence for association between the STin2.12 allele of the STin2 VNTR polymorphism (random-effects pooled OR ¼ 1.24, 95% CI ¼ 1.11-1.38, Z ¼ 3.82, P ¼ 0.00014) and schizophrenia was found from 12 population-based association studies consisting of 2177 cases and 2369 control subjects. Our meta-analysis suggests that the STin2.12 allele of the STin2 VNTR polymorphism is likely a risk factor for schizophrenia susceptibility. Our data imply that following completion of the International HapMap Project, a comprehensive evaluation of a set of markers that fully characterize the linkage disequilibrium relationships at the SLC6A4 gene should be tested in large well-characterized clinical samples in order to understand the role of this gene in schizophrenia susceptibility. Molecular Psychiatry (2005) 10, 928-938.
Introduction
Schizophrenia is a common and severe psychiatric illness that affects approximately 1% of the general population. Family, twin and adoption studies have clearly indicated that genetic factors are involved in the pathogenesis of schizophrenia. 1 Perhaps due to the complex inheritance patterns and broad chromosome regions identified in linkage studies of schizophrenia, attempts to identify susceptibility genes have so far had limited success. 1, 2 To date, candidate gene-based association studies have focused on genes encoding receptors and enzymes involved in metabolism, re-uptake or action of dopamine, serotonin, and glutamate neurotransmission. [3] [4] [5] In addition to its accepted role as a neurotransmitter, serotonin (5-HT) has been shown to regulate the development of the central nervous system (CNS). 6 The serotonin transporter protein, which plays a crucial role in regulating the intensity and duration of serotonergic signaling at synapses, has long been suggested as a promising candidate gene for various psychiatric disorders including schizophrenia. 6, 7 Further evidence implicating the serotonin transporter in the pathology of schizophrenia has come from studies using post-mortem tissues of the CNS. [8] [9] [10] Other serotonin signaling molecules are also candidate genes. Of note, a recent meta-analysis found significant association between a single nucleotide polymorphism (SNP) in the 5-HT2a receptor gene and schizophrenia in European populations. 11 The human serotonin transporter protein is encoded by a single gene (SLC6A4, LocusLink ID: 6532), mapped to chromosome 17q11.1-q12. 12 Two common polymorphisms in the SLC6A4 gene have been extensively studied in the genetic association studies.
A functional polymorphism (5-HTTLPR) in the 5 0 regulatory region involves two major alleles-termed 'S' (Short) and 'L' (Long) allele-that correspond to the presence of 14-or 16-repeat units of a 20-23 bp incomplete repeat. 13 Additional low frequency alleles have been identified including 15-, 18-, 19-, 20-and 22-repeat units. 14 The Short allele was found to reduce transcription efficiency for the SLC6A4 gene, resulting in decreased gene expression and serotonin uptake in lymphoblast cell lines. 13, 15 A second polymorphism, a 17 bp variable number of tandem repeats (termed STin2 VNTR), located in intron 2 involves two major alleles (termed 'STin2.10' and 'STin2.12') that correspond to 10-or 12-repeat units of the 17 bp VNTR. 16 Additional low-frequency alleles (termed 'STin2.7' and 'STin2.9') have been identified including seven-and nine-repeat units. 17 Although the biological function of the STin2 polymorphism, if any, has not been elucidated, the Stin2.12 allele has been reported to be a transcriptional enhancer. 18 Over the past decade, a large number of association studies between the two SLC6A4 gene polymorphisms and schizophrenia have been published. However, neither polymorphism has yet been confirmed as a susceptibility locus for schizophrenia, since neither association has been consistently confirmed in replication studies. While none of the previous association studies showed statistically significant evidence of association or linkage disequilibrium (LD) between the Short or Long allele of the 5-HTTLPR polymorphism and schizophrenia, 17, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] two previous studies found association of Long allele homozygotes with intensity of hallucinations or schizoaffective subtype of schizophrenia. 17, 36 On the other hand, three population-based association studies and one family-based association study have demonstrated the STin2.12 allele of STin2 polymorphism to be significantly associated with an increased vulnerability to schizophrenia. 17, 25, 37, 38 While a majority of the previous association studies failed to replicate such previous positive findings, most of them reported nonsignificant over-representation of the STin2.12 allele in schizophrenic patients. 22, 26, 28, 31, [33] [34] [35] [39] [40] [41] Ambiguous association study findings are not unusual for genetic analyses of complex genetic diseases. 42, 43 Many factors can contribute to variability in association study findings. Among them, small sample size leads to low statistical power of individual studies with a concomitant increased rate of both false-positive and false-negative results and subsequent difficulty replicating or refuting previous findings. 44 To deal with these ambiguities, metaanalysis of individual studies can be performed, thereby increasing power and allowing for a more global interpretation of all available data. [45] [46] [47] [48] In view of the conflicting results concerning the association between the two common SLC6A4 gene polymorphisms and schizophrenia, we pooled results of all published original association studies to determine the overall strength of putative association between the SLC6A4 gene polymorphisms and schizophrenia. Furthermore, the LD pattern of the SLC6A4 gene locus was examined in Centre d'Etude Polymorphisme Humain (CEPH) samples using the genotype data from the international HapMap project website (www.hapmap.org).
Method
Identification of relevant studies for inclusion Identification of relevant studies and choice of inclusion criteria were modeled on the methods of Faraone et al 49 and Glatt et al. 50 In brief, studies were identified in two ways. First, by searching for 'serotonin AND transporter AND schizophrenia' in PubMed up to April 2004. Second, by identification of studies by a thorough review of the references included in those studies that were listed in PubMed. There were three primary criteria used to judge whether a study could be included in the metaanalysis and they were examining the association between schizophrenia and the two common SLC6A4 gene polymorphisms, reporting of original data and ability to determine an odds ratio (OR) from the available data. When the original studies reported results on different samples, 21, 34, 35 we retained the distinction in our analyses. Authors were contacted in case of confusion about potentially overlapping study populations. Data from six studies were not included in the meta-analysis because genotype data were only available from patient subjects but not from control subjects. 36, [51] [52] [53] [54] [55] Another four studies were not included because data from those studies were not independent from the studies that were already in the analysis.
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Statistics Data for population-based association studies were analyzed as in the study of Faraone et al 49 and Glatt et al. 50 In the case of the STin2 VNTR with four alleles, two of which are rare (STin2.7 and STin2.9), we obtained ORs for the STin2.12 allele while clumping the STin2.7, STin2.9 and STin2.10 alleles together (represented by 'Other allele' in Table 2 ). ORs were calculated by using the Short allele for 5-HTTLPR polymorphism and STin2.12 allele for STin2 VNTR as the risk allele.
Prior to the pooling procedure, a w 2 -based Q statistic test was performed in order to assess the heterogeneity within the group of ORs. We calculated the pooled ORs according to the Mantel-Haenszel fixedeffects model and the DerSimonian-Laird randomeffects model. 60, 61 The random-effects method yields wider confidence intervals (CIs) when between-study heterogeneity exists, otherwise fixed-and randomeffects methods' estimates are similar. Absence of a statistically significant test of heterogeneity does not imply homogeneity, as such tests are generally weak. Thus, a more conservative approach is the randomeffects approach. In our study, estimated ORs are virtually identical for the fixed-and random-effects approaches, and we choose to report only results from the random-effects model as the CIs are more conservative. A series of pooled OR (and 95% CI) was determined in the absence of each individual study to evaluate the extent to which the pooled OR was affected by the inclusion of a single study.
We used the method of Egger et al 62 to assess the potential small-study effects-where the smaller studies show larger effects compared to larger studies, which used a linear regression approach to measure funnel plot asymmetry on the natural logarithm of the OR. The standard normal deviate of the estimated effect, defined as the Ln(OR) divided by its standard error, termed 'SND', is regressed against the estimate's precision, defined as the inverse of the standard error (SND ¼ a þ b Â Precision). If there is asymmetry, with smaller studies showing effects that differ systematically from larger studies, the regression line will not run through the origin. The intercept (a) provides a measure of asymmetry (the larger its deviation from zero, the more pronounced the asymmetry). The significance of the intercept (a) was determined by the t-test, and the significance level is set at Po0.1 as suggested by Egger et al.
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The transmission/disequilibrium test (TDT) was used to analyze family-based association studies. The OR was calculated from the ratio of transmissions to nontransmissions from heterozygous parents to affected offspring. 63, 64 The method described previously by Lohmueller et al 65 was utilized to calculate the combined effect size from both case-control and family-based association studies. To assess whether the result of the first significant publication contributed and inflated effect size to the pooled result, a Zscore statistic was calculated as described previously by Cappelleri et al.
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The LD structure of a 200 kb region on chromosome 17q11.2 including the human SLC6A4 gene was constructed using 36 SNPs. Genotype data were downloaded from the International HapMap Project website (www.hapmap.org) for 30 CEPH trios (Utah residents with ancestry from northern and western Europe). 67 Haplotype construction, counting and block defining were performed as described elsewhere, 68, 69 using Haploview software. 70 The multiallelic D 0 was computed by performing a series of pairwise D 0 calculations using each haplotype in turn as an allele, with all other haplotypes at the locus serving as the other allele. This is then repeated for each haplotype at each locus and averaged by haplotype frequency. 71 
Results

5-HTTLPR polymorphism
A total of 19 case-control and three family-based association studies met our criteria for inclusion in the meta-analysis. Table 1 shows the characteristics of the 22 studies.
Case-control studies: No statistically significant differences in allele frequencies were detected between the cases and controls for this polymorphism ( Table 1 ). The homogeneity analysis yielded a w 2 value of 9.3 (df ¼ 18; P ¼ 0.95), which suggests that there was no statistically significant evidence for heterogeneity of the ORs among the group of studies. The pooled OR derived from 19 individual studies, including 2990 cases and 3875 control subjects, is not statistically significant (random-effects pooled OR ¼ 0.99, 95% CI ¼ 0.92-1.07, Z ¼ À0.23, P ¼ 0.82). Sensitivity analysis generated a series of pooled ORs with 95% CIs that consistently encompassed 1.0, suggesting that the pooled OR was not excessively affected by the inclusion of any single study (data not shown). For the 19 case-control studies, the regression approach of Egger et al 62 did not find significant evidence (a ¼ À0.096, 90% CI ¼ À0.96 to 0.77; t ¼ À0.19, df ¼ 18, P ¼ 0.85) for small-study effects within this group of studies (Figure 1) .
Family-based studies: In three family-based association studies with a total of 518 family trios, we found no significant evidence for overtransmission of the Short allele from heterozygous parents to their schizophrenic offspring (199 transmitted vs 201 not transmitted, pooled OR TDT ¼ 0.99, P ¼ 0.92; Table 1 ).
Case-control and family-based studies: The combined effect size from both case-control and familybased association studies found no significant association between the 5-HTTLPR polymorphism and schizophrenia (random-effects pooled OR all ¼ 0.99, 95% CI ¼ 0.92-1.06, Z ¼ À0.25, P ¼ 0.803; Table 1 ).
STin2 VNTR polymorphism
A total of 12 case-control and four family-based association studies met our criteria for inclusion in the meta-analysis. Table 2 shows the characteristics of the 16 studies.
Case-control studies: Three individual studies found statistically significant differences in allele frequencies between patients and control subjects for this polymorphism (Table 2) . 17, 37, 38 The homogeneity analysis yielded a w 2 value of 13.2 (df ¼ 11; P ¼ 0.28), which suggests that there was no statistically significant evidence for heterogeneity of the ORs among the group of studies. The pooled OR derived from 12 case-control studies, including 2177 cases and 2369 control subjects, is highly statistically significant (random-effects pooled OR ¼ 1.24, 95% CI ¼ 1.11-1.38, Z ¼ 3.82, P ¼ 0.00014). Sensitivity analysis generated a series of pooled ORs ranging from 1.20 to 1.26 with 95% CIs that always excluded 1.0, suggesting that the pooled OR was not excessively affected by the inclusion of any single study (data not shown). For the 12 case-control studies, the regression approach of Egger et al 62 did not find significant evidence (a ¼ 0.99, 90% CI ¼ À0.43 to 2.41; t ¼ 1.27, df ¼ 11, P ¼ 0.23) for small-study effects within this group of studies ( Figure 1) .
Family-based studies: In four family-based association studies with a total of 784 family trios, we found statistically significant evidence for overtransmission of the STin2.12 allele of the STin2 VNTR Table 2 ), although the combined TDT result was highly influenced by the first significant TDT study. 25 Case-control and family-based studies: The combined effect size from both case-control and family-based association studies found significant association between the STin2 VNTR polymorphism and schizophrenia (random-effects pooled OR all ¼ 1.24, 95% CI ¼ 1.11-1.38, Z ¼ 3.91, P ¼ 0.00009; Table 2 ).
The Z-score statistic of Cappelleri et al 66 showed no statistically significant discrepancy between the first significant study and subsequent publications (Z ¼ À0.94, P ¼ 0.35). 37 Further analyses of subgroup studies There are six individual studies that examined both the 5-HTTLPR and STin2 VNTR polymorphisms in their samples. 17, 22, 26, 31, 34, 35 Meta-analysis based on this subgroup of individual studies also demonstrated highly significant association between the STin2.12 allele of the STin2 VNTR and schizophrenia (randomeffects pooled OR ¼ 1.21, 95% CI ¼ 1.09-1.34, Z ¼ 3.58, P ¼ 0.00034) but not for the Short allele of the 5-HTTLPR polymorphism (random-effects pooled OR ¼ 0.96, 95% CI ¼ 0.87-1.06, Z ¼ À0.85, P ¼ 0.39). Furthermore, the pooled OR derived for the STin2 VINTR polymorphism in Caucasian samples (n ¼ 9) was similar to that observed for the entire set of data (random-effects pooled OR ¼ 1.20, 95% CI ¼ 1.09-1.33, Z ¼ 3.67, P ¼ 0.00025). 17, 22, 26, 31, 34, 35, 37, 39 Structure of LD Association between schizophrenia and the STin2 VNTR but not the 5-HTTLPR polymorphism is supported by the LD analyses. The LD structure of the 200 kb region including the SLC6A4 gene and two nearby genes (DKFZP434K1421 and BLMH) in CEPH families is shown in Figure 2 . Previous data have demonstrated marked global variability in the pairwise D 0 calculated between the alleles of the two SLC6A4 polymorphisms. 72 These data are strongly supported by a current LD structure obtained from 30 CEPH trios. Using the block definition that defines 'strong LD' if the one-sided upper 95% confidence bound on D 0 40.98 as in Gabriel et al, 69 we find that there are three regions of strong LD. Block 1 contains the hypothetical gene DKFZP43K1421 and the 3 0 end of SLC6A4. A second small block of LD defined by rs2020942 and rs2066713 encompasses the STin2 VNTR. Although the conservative block definition we have used separates these blocks, there is no evidence for recombination between them with a multiallelic D 0 of 0.99. The third block of LD encompasses the BLMH gene with the 5-HTTLPR polymorphism in between blocks 2 and 3. There is evidence of historical recombination between blocks 2 and 3, and the multiallelic D 0 between blocks 2 and 3 is 0.51. Similar LD patterns were also observed in the Chinese and Japanese populations, while much lower LD was observed in the Yoruba population from African (data not shown).
Discussion
The SLC6A4 gene 5-HTTLPR polymorphism represents a strong biological candidate locus for various psychiatric disorders. 6 Several recent meta-analyses suggested that the Short allele plays a modest role in susceptibility to anxiety-related personality traits, suicidal behavior and bipolar disorder. [73] [74] [75] [76] [77] [78] On the basis of 19 population-based association studies including 2990 cases and 3875 control subjects, our meta-analysis showed no statistically significant association between the Short allele and schizophrenia (random-effects pooled OR ¼ 0.99, P ¼ 0.82). This finding is consistent with the results of previous association studies, since none of them showed statistically significant association between Short allele and schizophrenia. However, the functional 5-HTTLPR polymorphism may play a role in other personality traits or even as a modifying locus on the presentation of schizophrenia as suggested by previous studies. 17, 36, [73] [74] [75] [76] [77] In contrast to the results obtained for the promoter variant, our meta-analysis demonstrated a highly significant association between the STin2.12 allele 0 between the SNPs. D 0 was calculated using the program Haploview. 70 Maximum likelihood haplotype blocks were calculated using an EM algorithm as in the study by Gabriel et al.
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STin2 VNTR polymorphism and schizophrenia JB Fan and P Sklar of the STin2 VNTR polymorphism and schizophrenia (random-effects pooled OR ¼ 1.24, P ¼ 0.00014) on the basis of 12 population-based association studies including 2177 case and 2369 control subjects. This finding is not entirely unexpected since most of the individual studies (11 of 12 individual studies) showed over-representation of the STin2.12 allele in schizophrenic sample (OR41.0), although only three of them demonstrated statistically significant association. 17, 37, 38 Thus, many previous nonsignificant results likely resulted from the relatively low statistical power of the individual studies each of which comprised only a small number of subjects. Using the Genetic Power Calculator, 79 we determined that a sample of approximately 1300 cases and 1300 controls would be necessary to achieve a nominal significance of 0.05 with 80% power to detect effect sizes such as those we have found in the metaanalysis. Although it has been suggested that the first significant association study tends to overestimate the genetic effects, which often cannot be replicated in subsequent larger studies, 43 we find that there is no statistically significant discrepancy between the effects of first significant study and subsequent publications, and the STin2.12 allele of the STin2 VNTR polymorphism remained significantly associated with schizophrenia (Table 3 ) even after removing the first significant study. 37 The association found between the STin2 VNTR and schizophrenia is intriguing since no association was found for the nearby 5-HTTLPR polymorphism (B15 kb), which is one of the most widely studied polymorphisms in the psychiatric literature. However, we find no evidence that the data resulted from any single study, nor for small-study effects. It is noteworthy that the two groups of population-based association studies are not completely independent from each other. There are six individual studies that examined both the 5-HTTLPR and STin2 VNTR polymorphisms in their samples. 17, 22, 26, 31, 34, 35 Metaanalysis based on this subgroup of individual studies also demonstrated highly significant association between the STin2.12 allele of the STin2 VNTR and schizophrenia but not for the Short allele of the 5-HTTLPR polymorphism. In support of our observation that there is no heterogeneity between studies, the pooled OR derived for the STin2 VINTR polymorphism in Caucasian samples (n ¼ 9) was similar to that observed for the entire set of data. 17, 22, 26, 31, 34, 35, 37, 39 Taken together, these observations further support the idea that the STin2 VNTR is associated with schizophrenia rather than the nearby 5-HTTLPR polymorphism.
Variable patterns of LD have been observed between the 5-HTTLPR and STin2 polymorphisms. In the study of Gelernter et al, 72 LD was shown to vary from strong in native Americans to absent in Chinese, with Europeans having some LD. Recent empirical data have suggested that the LD patterns in the human genome are characterized by a 'haplotype block' structure, in which a series of high-LD regions are interspersed with short, discrete segments of very low LD. 68, 69 The haplotype block structure of the SLC6A4 gene region in CEPH samples shows that the 200 kb region can be described by three blocks of strong LD, where the 5-HTTLPR polymorphism localized in a weak LD region while the STin2 VNTR localized in a nearby short block of strong LD. Similar LD patterns were also observed in the Chinese and Japanese populations. The weak LD between these two polymorphisms may partly explain the differential association of the STin2 VNTR polymorphism with schizophrenia. This observation suggests that the 5-HTTLPR polymorphism is inadequate alone in testing comprehensively for association to SLC6A4 gene and highlights the value of evaluating patterns of LD across a candidate gene, rather than relying on one or few markers.
The allele frequencies of the 5-HTTLPR and STin2 VNTR polymorphisms in the control subjects across individual studies showed significant global variation (as shown in Tables 1 and 2 ), suggesting the potential for population stratification. However, empirical evidence suggests that the effects of population stratification can be kept to a minimum in welldesigned population-based association studies. 80 Most of the population-based association studies included in the current meta-analysis utilized case and control subjects from the same geographic region and ethnic origin, which may help to reduce the potential effects of stratification. Moreover, the effects of population stratification are likely to be in a random direction in any individual study, so that a small amount of stratification in any one individual study should have little effect on the pooled results. 64 Furthermore, the combined results from TDT studies, which are robust to population stratification, showed that the STin2.12 allele of the STin2 VNTR was significantly overtransmitted (P ¼ 0.025) from heterozygous parents to schizophrenic offspring. The combined TDT results should be interpreted with caution given the small number of studies and our observation that the combined result for the STin2 VNTR was highly influenced by the first significant TDT study. 25 Despite this, the pooled ORs derived from the population-based association studies and the TDT studies were similar in their magnitude (pooled OR case-control ¼ 1.24 vs pooled OR TDT ¼ 1.22), which provides some additional confidence that the overall significant association found in the population-based association studies is not due to population stratification. Furthermore, the combined result from both case-control and family-based association studies also supports significant association between the STin2 VNTR polymorphism and schizophrenia.
These results raise two further questions. First, does the STin2 VNTR affect the function of the SLC6A4 gene and second, is the STin2 VNTR causally associated with schizophrenia susceptibility. As yet, the biological function of the STin2 VNTR polymorphism is still not clearly elucidated. 81 The major norepinephrine metabolite (3-methoxy-4-hydroxy-phenylglycol, MHPG) level in lumbar cerebrospinal fluid (CSF) has been shown to be associated with the STin2 VNTR genotypes, with the highest MHPG levels in STin2.12/STin2.12 homozygotes. 82 Moreover, in vivo gene expression in transgenic mouse embryos has shown that both alleles of the STin2 VNTR (STin2.10 and STin2.12) can act as transcriptional regulatory elements, each having different enhancer-like properties within the developing rostral hindbrain where SLC6A4 is known to be expressed. 18 These findings are supported by in vitro data indicating that the STin2 VNTR may act as a tissue-specific transcriptional regulator of the SLC6A4 gene. 83 A more recent study showed that individual repeat elements within the STin2 VNTR domain differ in their enhancer activity in differentiating embryonic stem (ES) cells. 84 These observations taken together suggest that inappropriate levels of SLC6A4 gene expression found in the developing rostral hindbrain, driven by a stronger or weaker than normal transcriptional regulation, may lead to aberrant serotonin neuron development. 18 Although there is evidence for functional effects of alleles at the STin2 VNTR, it is not possible to determine if this VNTR is causally associated with increased risk of schizophrenia. The functional evidence is preliminary and furthermore, its interpretation in the context of the role of the serotonin transporter in schizophrenia is not yet clear. This marker is in relatively strong LD with a substantial portion of the SLC6A4 gene and the nearby human gene DKFZP434K1421, which encodes a hypothetical protein of unclear function. To date, no other functional polymorphism within the SLC6A4 has been identified except the 5-HTTLPR and STin2 VNTR, but given the focus on the promoter polymorphism, it is unlikely that systemic evaluation has occurred. Several recent reports have demonstrated genotypic control of mRNA expression and splicing by SNPs in the 3 0 UTR and in an intron that are strongly associated with diseases. 85, 86 Thus, in the future, a comprehensive evaluation of a set of markers that fully characterize the LD relationships at the SLC6A4 gene will need to be tested in order to dissect the relevance of SLC6A4 gene polymorphisms in schizophrenia susceptibility.
In conclusion, our meta-analysis suggests a modest but statistically significant effect of the STin2.12 allele of STin2 VNTR in susceptibility to schizophrenia but does not support the hypothesis that there is an overall association between the 5-HTTLPR polymorphism and schizophrenia.
